L-AP4

L-AP4
(IUPAC) ime
	(2S)-2-amino-4-fosfonobutanoinska kiselina
Klinički podaci
Identifikatori
CAS broj	23052-81-5
ATC kod	nije dodeljen
PubChem	179394
Hemijski podaci
Formula	C4H10NO5P
Mol. masa	183,099 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10) ; Key: DDOQBQRIEWHWBT-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

L-AP4 je lek koji se koristi u naučnim istraživanjima. On deluje kao agonist koji je selektivan za grupu III metabotropnih glutamatnih receptora (mGluR₄_/₆_/₇_/₈). On je bio privi ligand za koji je utvrđeno da deluje kao selektivni agonist za ovu grupu mGlu receptora.^[3] On se koristi u izučavanju ove receptorske familije i njihovih funkcija.^[4]^[5]^[6]^[7]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Thomsen C (1997). „The L-AP4 receptor”. General pharmacology 29 (2): 151–8. PMID 9251893.
↑ Lopez S, Turle-Lorenzo N, Acher F, De Leonibus E, Mele A, Amalric M (2007). „Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease”. Journal of Neuroscience 27 (25): 6701–11. DOI:10.1523/JNEUROSCI.0299-07.2007. PMID 17581957.
↑ MacInnes N, Duty S (2008). „Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo”. European journal of pharmacology 580 (1–2): 95–9. DOI:10.1016/j.ejphar.2007.10.030. PMID 18035348.
↑ Zhang HM, Chen SR, Pan HL (2009). „Effects of Activation of Group III Metabotropic Glutamate Receptors on Spinal Synaptic Transmission in a Rat Model of Neuropathic Pain”. Neuroscience 158 (2): 875–84. DOI:10.1016/j.neuroscience.2008.10.042. PMC 2649787. PMID 19017536.
↑ MacIejak P, Szyndler J, Turzyńska D, Sobolewska A, Taracha E, Skórzewska A, Lehner M, Bidziński A, Hamed A (2009). „The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration”. Brain research 1282: 20–7. DOI:10.1016/j.brainres.2009.05.049. PMID 19481536.

Vanjske veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Thomsen C (1997). „The L-AP4 receptor”. General pharmacology 29 (2): 151–8. PMID 9251893.

[4] Lopez S, Turle-Lorenzo N, Acher F, De Leonibus E, Mele A, Amalric M (2007). „Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease”. Journal of Neuroscience 27 (25): 6701–11. DOI:10.1523/JNEUROSCI.0299-07.2007. PMID 17581957.

[5] MacInnes N, Duty S (2008). „Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo”. European journal of pharmacology 580 (1–2): 95–9. DOI:10.1016/j.ejphar.2007.10.030. PMID 18035348.

[6] Zhang HM, Chen SR, Pan HL (2009). „Effects of Activation of Group III Metabotropic Glutamate Receptors on Spinal Synaptic Transmission in a Rat Model of Neuropathic Pain”. Neuroscience 158 (2): 875–84. DOI:10.1016/j.neuroscience.2008.10.042. PMC 2649787. PMID 19017536.

[7] MacIejak P, Szyndler J, Turzyńska D, Sobolewska A, Taracha E, Skórzewska A, Lehner M, Bidziński A, Hamed A (2009). „The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration”. Brain research 1282: 20–7. DOI:10.1016/j.brainres.2009.05.049. PMID 19481536.

[1]

[2]

[3]

[4]

[5]

[6]

[7]